ISSN ONLINE: 2558-815X
ISSN PRINT: 1584-9244
ISSN-L: 1584-9244

FDA Approves New Drug for Traveler’s Diarrhea (Aemcolo)

109 views

The US Food and Drug Administration (FDA) has approved the antibacterial agent rifamycin delayed-release tablets (Aemcolo, Cosmo Technologies) to treat adults with travelers’ diarrhea caused by noninvasive strains of Escherichia coli not complicated by fever or blood in the stool.

https://www.medscape.com/viewarticle/905316

 

Share.

Comments are closed.